Nanoprobe and uses thereof

TWI943549BActive Publication Date: 2026-10-21TAIPEI MEDICAL UNIV
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
TW114126069
Authority / Receiving Office
TW · TW
Patent Type
Patents
Current Assignee / Owner
Filing Date
2025-07-09
Publication Date
2026-10-21
Estimated Expiration
2045-07-08

Smart Images

  • Figure TWG2TB001917286_001
    Figure TWG2TB001917286_001
  • Figure TWG2TB001917286_002
    Figure TWG2TB001917286_002
  • Figure TWG2TB001917286_003
    Figure TWG2TB001917286_003
Patent Text Reader

Abstract

This article provides a nanoprobe comprising: a magnetic nanoparticle core and a coating layer. The coating layer encapsulates the magnetic nanoparticle core and comprises fucoidan or a derivative thereof, gelatin or a derivative thereof, and cationic macromolecules. This article also provides applications of this nanoprobe.
Need to check novelty before this filing date? Find Prior Art

Claims

1. A nanoprobe comprising: a magnetic nanoparticle (MNP) core; and a coating layer covering the magnetic nanoparticle core, the coating layer comprising: fucoidan or a derivative thereof; gelatin or a derivative thereof; and a cationic macromolecule.

2. The nanoprobe of claim 1, wherein the cationic macromolecule is selected from the group consisting of cationic polysaccharides, cationic polypeptides, and cationic proteins.

3. The nano probe as requested in claim 2, wherein the cationic macromolecule is protamine.

4. The nano probe of claim 1, wherein the weight ratio of the magnetic nanoparticles: the fucoidan or its derivatives: the gelatin or its derivatives: the cationic macromolecule is about 0-3:0.5-3:0-5:0.1-2.

5. The nano probe of claim 4, wherein the weight ratio of the magnetic nanoparticles: the fucoidan or its derivatives: the gelatin or its derivatives: the cationic macromolecule is about 1.35:0.8:1.6:0.

6.

6. The nano probe in request item 1 is a magnetic resonance imaging agent for thrombi.

7. Use of a nanoprobe as claimed in any one of claims 1 to 5 in the preparation of a contrast agent for magnetic resonance imaging.

8. Use of a nanoprobe as claimed in any one of claims 1 to 5 in the preparation of a pharmaceutical product for the detection or diagnosis of thrombosis-related diseases.

9. As requested in item 7, it is used to detect or diagnose the age and / or composition of thrombi.

10. As claimed in claim 8, wherein the thrombosis-related diseases include stroke, deep vein thrombosis, pulmonary embolism, and coronary thrombosis.

Citation Information

Patent Citations

  • Biocompatible magnetic materials

    TW201936212A

  • Fucoidan-quaternized chitosan nanoparticles and application thereof

    TW202108175A

  • Cell-nanoparticle drug delivery system and use of the same for inhibiting growth of tumor cells and diagnosing tumor cells

    TW202410909A